BRAF regulates circPSD3/miR-526b/RAP2A axis to hinder papillary thyroid carcinoma progression

Abstract Background Papillary thyroid carcinoma (PTC) is a common malignant tumor. BRAFV600E mutation has become a common molecular event in PTC pathogenesis. Circular RNA PSD3 (circPSD3) is known to be highly expressed in PTC. However, the bio-functional role of circPSD3 and its possible relationsh...

Full description

Saved in:
Bibliographic Details
Main Authors: Chuang Li, Xiaojuan Zhao, Jingge Zhao, Jing Zhao, Lemei An, Gang Wu
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Molecular and Cell Biology
Subjects:
Online Access:https://doi.org/10.1186/s12860-024-00528-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585308971991040
author Chuang Li
Xiaojuan Zhao
Jingge Zhao
Jing Zhao
Lemei An
Gang Wu
author_facet Chuang Li
Xiaojuan Zhao
Jingge Zhao
Jing Zhao
Lemei An
Gang Wu
author_sort Chuang Li
collection DOAJ
description Abstract Background Papillary thyroid carcinoma (PTC) is a common malignant tumor. BRAFV600E mutation has become a common molecular event in PTC pathogenesis. Circular RNA PSD3 (circPSD3) is known to be highly expressed in PTC. However, the bio-functional role of circPSD3 and its possible relationship with the BRAF in PTC is not clear. This study aims to probe the biofunction and molecular mechanism of circPSD3 in PTC pathogenesis. Methods RT-qPCR was utilized to measure the expression of circPSD3 and BRAF in PTC tissues and cells. The CCK-8 and EdU assays were employed to assess cell viability and proliferation. Cell apoptosis was quantified using flow cytometry. The migratory and invasive capabilities of the cells were evaluated via wound healing and transwell assays. The interaction between RNAs was investigated using luciferase reporter assay. Additionally, xenograft tumor experiments were conducted to validate our findings in vivo. Results Data showed that circPSD3 was highly expressed in PTC patients and cell lines. CircPSD3 was found to promote cell growth and migration and inhibit apoptosis in PTC cells. Results also revealed that circPSD3 upregulated RAP2A expression by specifically sponging miR-526b. Interestingly, inhibiting miR-526b reversed the tumorigenic properties of circPSD3 in PTC. Additionally, BRAF expression was low in PTC patients, and overexpression of BRAF hampered PTC development by downregulating circPSD3 and RAP2A while upregulating miR-526b expressions. Conclusions Our study reveals that circPSD3 is a key regulator promoting PTC progression via the circPSD3/miR-526b/RAP2A pathway. Furthermore, we found that overexpressing BRAF, which inhibits circPSD3, significantly hampers the progression of PTC.
format Article
id doaj-art-b01d62d68a364783a3d7d57ab08b7d80
institution Kabale University
issn 2661-8850
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Molecular and Cell Biology
spelling doaj-art-b01d62d68a364783a3d7d57ab08b7d802025-01-26T12:57:38ZengBMCBMC Molecular and Cell Biology2661-88502025-01-0126111510.1186/s12860-024-00528-2BRAF regulates circPSD3/miR-526b/RAP2A axis to hinder papillary thyroid carcinoma progressionChuang Li0Xiaojuan Zhao1Jingge Zhao2Jing Zhao3Lemei An4Gang Wu5Department of Ultrasound, Henan Provincial People’s HospitalDepartment of Ultrasound, Henan Provincial People’s HospitalDepartment of Clinical Scientific Research Service Center, Henan Provincial People’s HospitalDepartment of Ultrasound, Henan Provincial People’s HospitalDepartment of Rheumatology and Immunology, Henan Provincial People’s HospitalDepartment of Ultrasound, Henan Provincial People’s HospitalAbstract Background Papillary thyroid carcinoma (PTC) is a common malignant tumor. BRAFV600E mutation has become a common molecular event in PTC pathogenesis. Circular RNA PSD3 (circPSD3) is known to be highly expressed in PTC. However, the bio-functional role of circPSD3 and its possible relationship with the BRAF in PTC is not clear. This study aims to probe the biofunction and molecular mechanism of circPSD3 in PTC pathogenesis. Methods RT-qPCR was utilized to measure the expression of circPSD3 and BRAF in PTC tissues and cells. The CCK-8 and EdU assays were employed to assess cell viability and proliferation. Cell apoptosis was quantified using flow cytometry. The migratory and invasive capabilities of the cells were evaluated via wound healing and transwell assays. The interaction between RNAs was investigated using luciferase reporter assay. Additionally, xenograft tumor experiments were conducted to validate our findings in vivo. Results Data showed that circPSD3 was highly expressed in PTC patients and cell lines. CircPSD3 was found to promote cell growth and migration and inhibit apoptosis in PTC cells. Results also revealed that circPSD3 upregulated RAP2A expression by specifically sponging miR-526b. Interestingly, inhibiting miR-526b reversed the tumorigenic properties of circPSD3 in PTC. Additionally, BRAF expression was low in PTC patients, and overexpression of BRAF hampered PTC development by downregulating circPSD3 and RAP2A while upregulating miR-526b expressions. Conclusions Our study reveals that circPSD3 is a key regulator promoting PTC progression via the circPSD3/miR-526b/RAP2A pathway. Furthermore, we found that overexpressing BRAF, which inhibits circPSD3, significantly hampers the progression of PTC.https://doi.org/10.1186/s12860-024-00528-2Papillary thyroid carcinomacircRNAsmiRNAsPathogenesisMechanism
spellingShingle Chuang Li
Xiaojuan Zhao
Jingge Zhao
Jing Zhao
Lemei An
Gang Wu
BRAF regulates circPSD3/miR-526b/RAP2A axis to hinder papillary thyroid carcinoma progression
BMC Molecular and Cell Biology
Papillary thyroid carcinoma
circRNAs
miRNAs
Pathogenesis
Mechanism
title BRAF regulates circPSD3/miR-526b/RAP2A axis to hinder papillary thyroid carcinoma progression
title_full BRAF regulates circPSD3/miR-526b/RAP2A axis to hinder papillary thyroid carcinoma progression
title_fullStr BRAF regulates circPSD3/miR-526b/RAP2A axis to hinder papillary thyroid carcinoma progression
title_full_unstemmed BRAF regulates circPSD3/miR-526b/RAP2A axis to hinder papillary thyroid carcinoma progression
title_short BRAF regulates circPSD3/miR-526b/RAP2A axis to hinder papillary thyroid carcinoma progression
title_sort braf regulates circpsd3 mir 526b rap2a axis to hinder papillary thyroid carcinoma progression
topic Papillary thyroid carcinoma
circRNAs
miRNAs
Pathogenesis
Mechanism
url https://doi.org/10.1186/s12860-024-00528-2
work_keys_str_mv AT chuangli brafregulatescircpsd3mir526brap2aaxistohinderpapillarythyroidcarcinomaprogression
AT xiaojuanzhao brafregulatescircpsd3mir526brap2aaxistohinderpapillarythyroidcarcinomaprogression
AT jinggezhao brafregulatescircpsd3mir526brap2aaxistohinderpapillarythyroidcarcinomaprogression
AT jingzhao brafregulatescircpsd3mir526brap2aaxistohinderpapillarythyroidcarcinomaprogression
AT lemeian brafregulatescircpsd3mir526brap2aaxistohinderpapillarythyroidcarcinomaprogression
AT gangwu brafregulatescircpsd3mir526brap2aaxistohinderpapillarythyroidcarcinomaprogression